Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment ...

Innovative Study Design Focused on Early Proof-of-Concept Data The Phase I/IIa trial ... protocol is designed to deliver early, robust proof-of-concept data, advancing Ketamir-2's clinical ...

Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical ... for the trial is set to begin in Q1 2025, with initial safety and efficacy results from the Phase I study in ...

In the QUILT 106 trial, CD19-targeted high-affinity ... CD19+ and CD20+ relapsed/refractory B-cell NHL. The phase 1, open label clinical study is designed to enroll up to 10 participants and ...

The primary objective of this Phase 1 randomized, double-blind, placebo-controlled, multi-part single and multiple ascending dose clinical study is to ... approvals for trial commencement ...

today announced results from its Phase 1 clinical trial of VENT-03, the first cyclic GMP-AMP synthase (cGAS) inhibitor to successfully complete a first-in-human study. The Phase 1 trial evaluated ...

Zura Bio (ZURA) “announced the submission of a protocol to its open Investigational New Drug application with the U.S. Food and Drug ...

In this ongoing open-label, multicenter, dose-escalation Phase ... a Clinical Trial Collaboration Agreement with Merck (known as MSD outside of the US and Canada), for a Pyxis Oncology-sponsored study ...

The phase 1, open label clinical study is designed to enroll up to 10 participants and is being conducted in Johannesburg, Pretoria, and Bloemfontein, South Africa. “This trial is important for ...

IDE275 (GSK959) development is progressing into First-in-Human Phase 1 clinical trial(s) for the treatment of MSI-High solid tumors, representing IDEAYA's 5 th potential first-in-class clinical ...